Related references
Note: Only part of the references are listed.Switching Anti Vascular Endothelial Growth Factor Therapy for Neovascular Age-Related Macular Degeneration
Andrew P. Schachat
AMERICAN JOURNAL OF OPHTHALMOLOGY (2013)
Twelve-Month Efficacy and Safety of 0.5 mg or 2.0 mg Ranibizumab in Patients with Subfoveal Neovascular Age-related Macular Degeneration
Brandon G. Busbee et al.
OPHTHALMOLOGY (2013)
The SECURE Study Long-Term Safety of Ranibizumab 0.5 mg in Neovascular Age-related Macular Degeneration
Rufino Silva et al.
OPHTHALMOLOGY (2013)
Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
Nicholas Papadopoulos et al.
ANGIOGENESIS (2012)
Bevacizumab and ranibizumab tachyphylaxis in the treatment of choroidal neovascularisation
Julie L. Gasperini et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2012)
Loss of reactivity in intravitreal anti-VEGF therapy: tachyphylaxis or tolerance?
Susanne Binder
BRITISH JOURNAL OF OPHTHALMOLOGY (2012)
HORIZON: An Open-Label Extension Trial of Ranibizumab for Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
Michael A. Singer et al.
OPHTHALMOLOGY (2012)
Ranibizumab and Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration
Daniel F. Martin et al.
OPHTHALMOLOGY (2012)
Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
Jeffrey S. Heier et al.
OPHTHALMOLOGY (2012)
Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration The CATT Research Group
Daniel F. Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Evaluation of Injection Frequency and Visual Acuity Outcomes for Ranibizumab Monotherapy in Exudative Age-related Macular Degeneration
Hajir Dadgostar et al.
OPHTHALMOLOGY (2009)
Ranibizumab versus Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Two-Year Results of the ANCHOR Study
David M. Brown et al.
OPHTHALMOLOGY (2009)
TACHYPHYLAXIS AFTER INTRAVITREAL BEVACIZUMAB FOR EXUDATIVE AGE-RELATED MACULAR DEGENERATION
Farzin Forooghian et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2009)
Is There Tachyphylaxis to Intravitreal Anti-Vascular Endothelial Growth Factor Pharmacotherapy in Age-Related Macular Degeneration?
Shlomit Schaal et al.
OPHTHALMOLOGY (2008)
Ranibizumab for neovascular age-related macular degeneration
Philip J. Rosenfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Placental growth factor, a member of the VEGF family, contributes to the development of choroidal neovascularization
JM Rakic et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2003)
A computerized method of visual acuity testing: Adaptation of the early treatment of diabetic retinopathy study testing protocol
RW Beck et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2003)
Vascular permeability factor/vascular endothelial growth factor: A critical cytokine in tumor angiogenesis and a potential target for diagnosis and therapy
HF Dvorak
JOURNAL OF CLINICAL ONCOLOGY (2002)
Share Paper
